Evidence map›Paper›PMID 24398155›Full record

ArticleParasites & vectors2014

Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen.

Alessandra Torina, Juan A Moreno-Cid, Valeria Blanda, Isabel G Fernández de Mera, José M Pérez de la Lastra, Salvatore Scimeca, Marcellocalogero Blanda, Maria Elena Scariano, Salvatore Briganò, Rosaria Disclafani and 6 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Molecular Detection ofAnimals : an open access journal from MDPI · 2024
    Article
  3. Review
  4. Article
  5. Evolution of tick vaccinology.Parasitology · 2024
    Review
  6. Article
  7. Universal Tick Vaccines: Candidates and Remaining Challenges.Animals : an open access journal from MDPI · 2023
    Review
  8. Tick Vaccines and Concealed versus Exposed Antigens.Pathogens (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Functional Evolution of Subolesin/Akirin.Frontiers in physiology · 2018
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Alessandra Torina
Juan A Moreno-Cid
Valeria Blanda
Isabel G Fernández de Mera
José M Pérez de la Lastra
Salvatore Scimeca
Marcellocalogero Blanda
Maria Elena Scariano
Salvatore Briganò
Rosaria Disclafani
Antonio Piazza
Joaquín Vicente
Christian Gortázar
Santo Caracappa
Rossella Colomba Lelli
José de la FuenteSaBio, Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ronda de Toledo s/n, 13005, Ciudad Real, Spain. jose_delafuente@yahoo.com.
Istituto Zooprofilattico Sperimentale Della Sicilia · ITInstituto de Investigación en Recursos Cinegéticos · ESOklahoma State University · USUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the use of chemical acaricides, tick infestations continue to affect animal health and production worldwide. Tick vaccines have been proposed as a cost-effective and environmentally friendly alternative for tick control. Vaccination with the candidate tick protective antigen, Subolesin (SUB), has been shown experimentally to be effective in controlling vector infestations and pathogen infection. Furthermore, Escherichia coli membranes containing the chimeric antigen composed of SUB fused to Anaplasma marginale Major Surface Protein 1a (MSP1a) (SUB-MSP1a) were produced using a simple low-cost process and proved to be effective for the control of cattle tick, Rhipicephalus (Boophilus) microplus and R. annulatus infestations in pen trials. In this research, field trials were conducted to characterize the effect of vaccination with SUB-MSP1a on tick infestations and the prevalence of tick-borne pathogens in a randomized controlled prospective study.

methodsTwo cattle and two sheep farms with similar geographical locations and production characteristics were randomly assigned to control and vaccinated groups. Ticks were collected, counted, weighed and classified and the prevalence of tick-borne pathogens at the DNA and serological levels were followed for one year prior to and 9 months after vaccination.

resultsBoth cattle and sheep developed antibodies against SUB in response to vaccination. The main effect of the vaccine in cattle was the 8-fold reduction in the percent of infested animals while vaccination in sheep reduced tick infestations by 63%. Female tick weight was 32-55% lower in ticks collected from both vaccinated cattle and sheep when compared to controls. The seroprevalence of Babesia bigemina was lower by 30% in vaccinated cattle, suggesting a possible role for the vaccine in decreasing the prevalence of this tick-borne pathogen. The effect of the vaccine in reducing the frequency of one A. marginale msp4 genotype probably reflected the reduction in the prevalence of a tick-transmitted strain as a result of the reduction in the percent of tick-infested cattle.

conclusionsThese data provide evidence of the dual effect of a SUB-based vaccine for controlling tick infestations and pathogen infection/transmission and provide additional support for the use of the SUB-MSP1a vaccine for tick control in cattle and sheep.

Indexed as

AnimalsAntibodiesAntigensArthropod ProteinsBacterial Outer Membrane ProteinsCattleCattle DiseasesGenotypeMolecular Sequence DataPrevalenceSheepSheep DiseasesTick InfestationsTicksVaccinationVaccinesAntibodiesAntigensArthropod ProteinsBacterial Outer Membrane Proteinsmajor surface protein 1a, Anaplasmasubolesin, tickVaccines

Identifiers

PMID24398155
PMCPMC3896746
OpenAlexW2143024331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.